Tom Xu

Combined Hepatocellular Cholangiocarcinomas; Analysis of a Large Database (2008)

Mitchell S. Wachtel, Yan Zhang, Tom Xu, Maurizio Chiriva-Internati, Eldo E Frezza

Aim: Combined hepatocellular cholangiocarcinoma (combined tumor) has been described as either a variant of hepatoma or a variant of cholangiocarcinoma. Prior studies evaluated fewer than 50 patients...

Cost-effectiveness of intermediate or long-acting insulin versus Exenatide in type 2 diabetes mellitus patients not optimally controlled on dual oral diabetes medications (2006)

Edwards, Krystal L., Irons, Brian K., Xu, Tom

Objective: To better understand exenatide¿s role in the treatment of type 2 diabetes, this analysis assessed its cost-effectiveness in comparison to an intermediate (NPH) and long-acting insulin...